1 Min Read
April 22 (Reuters) - Canada's Valeant Pharmaceuticals International Inc said it offered to buy Botox maker Allergan Inc to boost its skin and eye-care portfolio.
Valeant said it had offered to pay $48.30 per share in cash and 0.83 of its common share for each Allergan share.
The company said Bill Ackman's Pershing Square, Allergan's largest shareholder with a 9.7 percent stake, supported the deal. (Reporting by Esha Dey in Bangalore; Editing by Saumyadeb Chakrabarty)